WASHINGTON, D.C. -- Congress approved the $40 billion budget reconciliation bill for 2006 last month, after it was sidelined for weeks by opponents. The measure reduces some crop support programs and student loans, but the bulk of the savings comes from changes to Medicaid and Medicare: $11 billion over the next five years and nearly $50 billion over 10 years.
WASHINGTON, D.C.-Congress approved the $40 billion budget reconciliation bill for 2006 last month, after it was sidelined for weeks by opponents. The measure reduces some crop support programs and student loans, but the bulk of the savings comes from changes to Medicaid and Medicare: $11 billion over the next five years and nearly $50 billion over 10 years.
One significant revision affects the method for calculating Medicare payments to Medicare Advantage (MA) plans. Although some additional payment curbs fell by the wayside during final negotiations over the legislation, a change in how Medicare calculates risk adjustment to MA plans could reduce plan payments by more than $10 billion over the next 10 years.
The legislation changes the schedule for phasing out the "budget neutrality" adjustment to payment rates, which currently returns to MA plans all of the savings that would result from application of risk adjustment based on beneficiary health status. However, the bill leaves it to the Centers for Medicaid and Medicare Services (CMS) to implement this rate adjustment, which opens the door to scaling back the revision before it is fully implemented.
These are offset by a provision that cancels a major cut in fees for physicians. Instead of a 4.4% reduction, rates will increase during the next three years and moderate slightly after that.
CHANGES CAUSE A STIR
The Medicaid program faces significant change that generated an outcry from healthcare providers and consumer groups.
The budget bill restricts coverage of nursing home care for people with sizeable assets, and states gained leeway to reduce Medicaid benefits and to levy copays for certain services and drugs, which is projected to end coverage for about 45,000 enrollees by 2010 because they will be unable to pay new premiums and copays, according to the Congressional Budget Office. Patient advocates blasted these proposals as likely to deny Medicaid services to thousands of low-income individuals.
About half of the Medicaid savings come from provisions that reduce payments for prescription drugs. Pharmacists face cuts in dispensing fees, and brand-name pharmaceutical companies may find it harder to block generic competition.
Despite opposition from patient groups and some healthcare providers, the budget bill squeaked by with strong support from physicians desperate to cancel the doctors' fee cut and conservative Republicans who saw the measure as a chance to control some runaway federal spending.
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen